Laboratory Orders for CD4 and Viral Load in Newly Diagnosed HIV-Positive Pregnant Women
For a 23-year-old pregnant woman newly diagnosed with HIV, order a baseline CD4+ T-lymphocyte count and quantitative HIV-1 RNA viral load (plasma HIV RNA) immediately at diagnosis, before initiating antiretroviral therapy.
Specific Laboratory Requests
Initial Baseline Testing (At Diagnosis)
- CD4+ T-lymphocyte count (absolute count and percentage) 1, 2
- Quantitative HIV-1 RNA viral load (plasma HIV RNA level) 1, 2
The CD4 percentage may be more stable and accurate during pregnancy than absolute count due to physiologic changes in blood volume and hemodynamic parameters 1.
Testing Methods and Specifications
For Viral Load Testing
Request one of the FDA-approved quantitative assays 3:
- RT-PCR (reverse transcriptase-polymerase chain reaction)
- bDNA (branched DNA assay)
- NucliSens HIV-1 QT assay
Results should be reported in both copies/mL and log10 transformation 4. Choose one assay method and use it consistently for all subsequent monitoring, as different assays can vary by more than 2-fold 4.
For CD4 Count Testing
- Request both absolute CD4+ count (cells/mm³) and CD4+ percentage
- CD4 percentage is preferred during pregnancy for more accurate immune status assessment 1
Monitoring Schedule After Initial Testing
During Pregnancy
- Repeat CD4 count: Every 3-4 months (approximately once per trimester) 1, 3
- Repeat viral load: Every 3-4 months 1, 3
- After ART initiation: Viral load at 2-8 weeks to assess treatment response 3
Critical Timing Considerations
The first viral load after starting ART should show substantial decrease (≥1.0 log10) by 2-8 weeks, with goal of undetectable levels (<50 copies/mL) by 16-24 weeks 3. For pregnant women, viral load at 36 weeks gestation is particularly important for delivery planning 2.
Additional Baseline Laboratory Tests
Beyond CD4 and viral load, comprehensive baseline testing should include 5, 6:
- Complete blood count with differential
- Kidney function (creatinine)
- Liver function tests
- Lipid panel
- Blood glucose
- Hepatitis A, B, and C serology
- Syphilis and other STI screening
- Tuberculosis screening
- Pregnancy confirmation
Important Clinical Caveats
Do not delay ART initiation while waiting for these results 5, 6. Treatment should begin immediately after HIV diagnosis in pregnancy, with rapid follow-up of laboratory results to ensure safety and optimize therapy.
For women with CD4 counts <100 cells/μL, add serum cryptococcal antigen testing even without symptoms 5, 6.
The viral load threshold of >1,000 copies/mL is clinically significant for determining need for combination therapy versus monotherapy prophylaxis and for cesarean delivery planning 2, 7.